MedTrace Logo

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

NCT01993823 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2017-04-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of G238 for the treatment of otomycosis

Conditions

  • Otomycosis

Interventions

DRUG

G238

Five drops into the ear canal twice daily for 14 days

DRUG

Clotrimazole

Five drops into the ear canal twice daily for 14 days

Sponsors & Collaborators

  • Salvat

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993823 on ClinicalTrials.gov